Search results

Sort By: Newest first | Oldest first

  • Defining innovation in a changing healthcare landscape weblink

    Briefings | 9 September 2014

    Digital technology and big data might help the industry reboot its relationship with patients and loosen its dependence on old-fashioned blockbuster drug development.

  • Connected health: capturing digital opportunites weblink

    Briefings | 6 June 2014

    At the start of 2014, Neelie Kroes, head of the European Commission’s digital agenda, remarked that ‘virtually every business is a digital business now’.

  • New clinical trial rules in the EU: a first overview weblink

    Briefings | 4 June 2014

    Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use has been published in the Official Journal of the European Union.

  • Biosimilar substitution in France: no way back? weblink

    Briefings | 10 January 2014

    French pharmacists can now substitute a biosimilar for the prescribed (reference) biological medicine as long as the prescribing physician has not marked the prescription as ‘non-substitutable’.

  • Second medical use patents weblink

    Briefings | 12 September 2013

    Patent cliffs remain one of the biggest issues facing the pharmaceutical industry.

  • Early disclosure of evaluation documents in public procurement dispute weblink

    Briefings | 12 June 2013

    In Roche Diagnostics Ltd v Mid Yorkshire Hospitals NHS Trust, an unsuccessful tenderer was entitled to both specific and pre-action disclosure in a public procurement dispute in relation to two related contracts.

  • Transparency of clinical trials data weblink

    Briefings | 31 May 2013

    This document contains an overview of current rules on access to clinical trials data, an overview of the anticipated legislative changes and a summary of the issues that the new regulation may bring.